Stock DNA
Pharmaceuticals & Biotechnology
CNY 7,450 Million (Mid Cap)
49.00
NA
0.48%
-0.75
10.48%
4.34
Revenue and Profits:
Net Sales:
227 Million
(Quarterly Results - Sep 2025)
Net Profit:
56 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-32.97%
0%
-32.97%
6 Months
2.91%
0%
2.91%
1 Year
65.85%
0%
65.85%
2 Years
-7.09%
0%
-7.09%
3 Years
23.78%
0%
23.78%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%
Mingyue Optical Lens Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
11.57%
EBIT Growth (5y)
22.63%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.74
Sales to Capital Employed (avg)
0.47
Tax Ratio
13.54%
Dividend Payout Ratio
56.77%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
38.04%
ROE (avg)
9.29%
Valuation key factors
Factor
Value
P/E Ratio
49
Industry P/E
Price to Book Value
5.18
EV to EBIT
39.40
EV to EBITDA
30.45
EV to Capital Employed
16.01
EV to Sales
9.56
PEG Ratio
36.82
Dividend Yield
0.41%
ROCE (Latest)
40.65%
ROE (Latest)
10.56%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Bullish
Dow Theory
No Trend
Mildly Bullish
OBV
No Trend
Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Sep'25 - YoY
Sep'25
Sep'24
Change(%)
Net Sales
227.20
198.30
14.57%
Operating Profit (PBDIT) excl Other Income
56.00
64.00
-12.50%
Interest
0.40
0.10
300.00%
Exceptional Items
5.60
4.60
21.74%
Consolidate Net Profit
55.90
50.90
9.82%
Operating Profit Margin (Excl OI)
246.50%
254.40%
-0.79%
USD in Million.
Net Sales
YoY Growth in quarter ended Sep 2025 is 14.57% vs 0.66% in Sep 2024
Consolidated Net Profit
YoY Growth in quarter ended Sep 2025 is 9.82% vs 9.70% in Sep 2024
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
763.60
742.50
2.84%
Operating Profit (PBDIT) excl Other Income
239.10
218.30
9.53%
Interest
0.50
0.70
-28.57%
Exceptional Items
21.20
26.80
-20.90%
Consolidate Net Profit
188.00
172.80
8.80%
Operating Profit Margin (Excl OI)
238.30%
222.10%
1.62%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is 2.84% vs 20.30% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is 8.80% vs 16.68% in Dec 2023
About Mingyue Optical Lens Co., Ltd. 
Mingyue Optical Lens Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






